Vir Biotechnology Inc.

VIR:NASDAQ

Vir Biotechnology is a clinical-stage immunology company focused on treating and preventing serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes.

streetwise book logo Streetwise Company Fact Sheet

2024/4/19 19:59:27

(VIR:NASDAQ)